Twin Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14M Sell
15,229
-424
-3% -$430K 1.81% 8
2025
Q4
$16.8M Sell
15,653
-108
-0.7% -$103K 2.09% 8
2025
Q3
$12M Sell
15,761
-3,615
-19% -$2.69M 1.51% 10
2025
Q2
$15.1M Buy
19,376
+1,429
+8% +$1.11M 1.61% 9
2025
Q1
$14.8M Sell
17,947
-363
-2% -$302K 1.73% 8
2024
Q4
$14.1M Buy
18,310
+259
+1% +$214K 1.55% 10
2024
Q3
$16M Buy
18,051
+331
+2% +$298K 1.8% 8
2024
Q2
$16M Buy
17,720
+2,758
+18% +$2.21M 1.89% 8
2024
Q1
$11.6M Buy
14,962
+627
+4% +$446K 1.44% 10
2023
Q4
$8.36M Sell
14,335
-4,749
-25% -$2.77M 1.09% 15
2023
Q3
$10.3M Buy
19,084
+1,721
+10% +$887K 1.47% 12
2023
Q2
$8.14M Buy
17,363
+2,348
+16% +$985K 1.06% 16
2023
Q1
$5.16M Sell
15,015
-3,612
-19% -$1.22M 0.7% 25
2022
Q4
$6.82M Sell
18,627
-295
-2% -$105K 0.88% 19
2022
Q3
$6.12M Buy
18,922
+979
+5% +$310K 0.83% 23
2022
Q2
$5.82M Buy
17,943
+806
+5% +$242K 0.74% 27
2022
Q1
$4.91M Sell
17,137
-420
-2% -$108K 0.53% 46
2021
Q4
$4.85M Buy
17,557
+2,432
+16% +$617K 0.49% 50
2021
Q3
$3.5M Sell
15,125
-15,752
-51% -$3.89M 0.36% 85
2021
Q2
$7.09M Sell
30,877
-8,715
-22% -$1.75M 0.65% 32
2021
Q1
$7.4M Sell
39,592
-6,860
-15% -$1.34M 0.74% 27
2020
Q4
$7.84M Sell
46,452
-2,306
-5% -$344K 0.71% 32
2020
Q3
$7.22M Buy
48,758
+1,562
+3% +$242K 0.65% 37
2020
Q2
$7.75M Sell
47,196
-2,064
-4% -$317K 0.75% 29
2020
Q1
$6.83M Buy
49,260
+185
+0.4% +$25.4K 0.74% 32
2019
Q4
$6.45M Sell
49,075
-16,180
-25% -$1.88M 0.55% 48
2019
Q3
$7.3M Sell
65,255
-5,255
-7% -$585K 0.53% 51
2019
Q2
$7.81M Sell
70,510
-44,340
-39% -$5.22M 0.54% 49
2019
Q1
$14.9M Sell
114,850
-17,716
-13% -$2.15M 0.73% 34
2018
Q4
$15.3M Sell
132,566
-1,324
-1% -$148K 0.86% 30
2018
Q3
$14.4M Buy
133,890
+3,630
+3% +$363K 0.66% 38
2018
Q2
$11.1M Buy
130,260
+4,330
+3% +$356K 0.56% 47
2018
Q1
$9.74M Buy
125,930
+33,510
+36% +$2.7M 0.5% 58
2017
Q4
$7.81M Buy
92,420
+2,090
+2% +$178K 0.38% 81
2017
Q3
$7.73M Buy
90,330
+41,150
+84% +$3.38M 0.41% 76
2017
Q2
$4.05M Buy
49,180
+4,800
+11% +$392K 0.24% 133
2017
Q1
$3.73M Buy
44,380
+33,220
+298% +$2.66M 0.23% 136
2016
Q4
$821K Sell
11,160
-55,460
-83% -$4.13M 0.05% 290
2016
Q3
$5.35M Buy
66,620
+33,980
+104% +$2.72M 0.36% 90
2016
Q2
$2.57M Sell
32,640
-1,300
-4% -$97.9K 0.19% 150
2016
Q1
$2.44M Sell
33,940
-6,480
-16% -$490K 0.19% 150
2015
Q4
$3.41M Buy
40,420
+15,250
+61% +$1.27M 0.28% 108
2015
Q3
$2.11M Buy
25,170
+1,100
+5% +$92.9K 0.2% 149
2015
Q2
$2.01M Sell
24,070
-10,800
-31% -$823K 0.18% 158
2015
Q1
$2.53M Hold
34,870
0.22% 141
2014
Q4
$2.41M Buy
34,870
+29,170
+512% +$1.97M 0.23% 130
2014
Q3
$370K Sell
5,700
-24,590
-81% -$1.56M 0.04% 269
2014
Q2
$1.88M Sell
30,290
-2,890
-9% -$172K 0.19% 158
2014
Q1
$1.95M Sell
33,180
-51,640
-61% -$2.88M 0.21% 156
2013
Q4
$4.33M Sell
84,820
-2,040
-2% -$102K 0.46% 53
2013
Q3
$4.37M Buy
86,860
+6,780
+8% +$355K 0.47% 54
2013
Q2
$3.93M Buy
+80,080
New +$4.36M 0.42% 57

Other funds holding LLY

Twin Capital Management's LLY Position: Q1 2026 in Review

Twin Capital Management reduced its Eli Lilly (LLY) stake by 2.7% in Q1 2026, selling an estimated $430K and leaving 15,229 shares worth $14M. The position accounts for 1.81% of the portfolio, ranked #8.

Twin Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.8M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Twin Capital Management held 15,229 shares of Eli Lilly worth $14M as of Q1 2026.
  • Twin Capital Management sold 424 Eli Lilly shares in Q1 2026, an estimated $430K.
  • Eli Lilly made up 1.81% of Twin Capital Management's portfolio in Q1 2026, its #8 holding.
  • Twin Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Twin Capital Management's Eli Lilly position peaked at $16.8M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.